Q1 FY27 results: Revenue up 12% YoY at Rs 8.77 cr, PAT at Rs 31.83 lakh

Results View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.6%Reaction day

₹27.28

prior close

₹27.99

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.3%+1.3% vs market

Commodity Chemicals peers, median of 52sector-0.5%+3.1% vs sector

On the reaction day the stock moved 1.3 pts more than Nifty Microcap 250 and 3.1 pts more than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.6+1.3+1.3-0.5+3.1

Next day

+2.3+1.6+0.6-0.6+2.9

+1.0+1.7-0.7-1.3+2.3

—+1.6—-0.8—

-4.0+1.5-5.4-1.3-2.7

-2.5+1.8-4.4-1.4-1.1

-7.4+2.1-9.4-0.0-7.3

15d

—+3.2—-1.4—

-4.3+3.7-8.0+0.4-4.7

-4.5+1.1-5.6+0.7-5.2

—————

UpDownMarket · Nifty Microcap 250Sector · Commodity Chemicals peers, median of 52Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Link Pharma Chem posted Q1 FY27 unaudited results with revenue from operations at Rs 8.77 crores vs Rs 7.81 crores in Q1 FY26, up about 12 percent YoY. Total income was Rs 9.12 crores. PAT stood at Rs 31.83 lakhs versus Rs 40.19 lakhs in Q1 FY26, down about 21 percent YoY. Sequentially, the company swung from a loss of Rs 40.86 lakhs in Q4 FY26 to a profit. EPS for the quarter was Rs 0.72 versus Rs 0.91 earlier. Auditor CNK and Associates LLP issued an unqualified review report.

Likely market impact

Sequential recovery from loss is positive, but YoY profit decline of 21 percent and modest revenue growth suggest mixed performance for shareholders.